CIK: 0001631614
Total reported value
$43.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | WVE | Wave Life Sciences Ltd. | Stock-Other | 18.33% | — | — | |
| 2 | ✓ | Versartis INC | Stock-Other | 17.98% | — | — | |
| 3 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 17.57% | — | — | |
| 4 | OXLC | Oxford Lane Capital Corp. | Stock-Other | 12.46% | — | — | |
| 5 | ✓ | Dimension Therapeutics INC | Stock-Other | 11.85% | — | — | |
| 6 | ALDR1EUR | Alder Biopharmaceuticals INC | Stock-Other | 5.45% | — | +21.04% | |
| 7 | DERMEUR | Dermira INC | Stock-Other | 4.72% | — | -1.32% | |
| 8 | SG7 | Sage Therapeutics INC | Stock-Other | 4.40% | — | -15.47% | |
| 9 | DVAX | Dynavax Technologies CORP | Stock-Other | 3.02% | — | -11.98% | |
| 10 | AVEOEUR | Aveo Pharmaceuticals INC | Stock-Other | 1.66% | — | — | |
| 11 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 1.07% | — | — | |
| 12 | TREUR | Trillium Therapeutics INC | Stock-Other | 0.86% | — | — | |
| 13 | ✓ | Inotek Pharmaceuticals CORP | Stock-Other | 0.34% | — | — | |
| 14 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 0.28% | — | -56.70% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | WVE | Wave Life Sciences Ltd. | +4.4% | — | Unchanged |
| 2 | OXLC | Oxford Lane Capital Corp. | +1.8% | — | Unchanged |
| 3 | ALDR1EUR | Alder Biopharmaceuticals INC | +1.4% | +21.04% | Add |
| 4 | ✓ | Dimension Therapeutics INC | +1.2% | — | Unchanged |
| 5 | SG7 | Sage Therapeutics INC | +0.3% | -15.47% | Trim |
| 6 | TREUR | Trillium Therapeutics INC | +0.2% | — | Unchanged |
| 7 | VTGNUSD | Vistagen Therapeutics INC | -0.1% | — | Unchanged |
| 8 | DERMEUR | Dermira INC | -0.2% | -1.32% | Trim |
| 9 | AVEOEUR | Aveo Pharmaceuticals INC | -0.5% | — | Unchanged |
| 10 | ADAPY | Adaptimmune Therapeutics-adr | -0.6% | -56.70% | Trim |
| 11 | ✓ | Versartis INC | -1.4% | — | Unchanged |
| 12 | DVAX | Dynavax Technologies CORP | -2.7% | -11.98% | Trim |
| 13 | EWTX | Edgewise Therapeutics, Inc. | -2.8% | — | Unchanged |
| 14 | KPTIEUR | Karyopharm Therapeutics INC | — | EXIT | Sold out |
| 15 | ✓ | Inotek Pharmaceuticals CORP | — | NEW | New buy |